Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Oncology Institute Affirms FY2025 Sales Guidance of $460.000M-$480.000M vs $465.100M Est

Author: Benzinga Newsdesk | August 13, 2025 03:08pm
Oncology Institute (NASDAQ:TOI) affirms FY2025 sales outlook from $460.000 million-$480.000 million to $460.000 million-$480.000 million vs $465.100 million estimate.

Posted In: TOI

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist